HKG:2269

2 stories mentioning HKG:2269Updated 7h ago

Every FINWIRES story that references HKG:2269, newest first.

CANbridge Pharmaceuticals Enters Service Agreements With WuXi Biologics, Baheal Medical

CANbridge Pharmaceuticals (HKG:1228) entered service procurement framework agreements with WuXi Biologics and Baheal Medical, according to a Tuesday Hong Kong bourse filing.Under the agreement, WuXi Biologics (HKG:2269) will provide contract research, development, and manufacturing organization services to CANbridge through 2028.Meanwhile, Baheal Medical will provide logistics, warehousing, and other supporting services through 2028.

HKG:1228HKG:2269

Asia22d ago

WuXi Biologics to Conduct Up to $400 Million Share Buyback; Shares Up 4%

WuXi Biologics (Cayman) (HKG:2269) said it plans to buy back up to $400 million of its shares from the open market, according to a filing with the Hong Kong bourse.The company said its current share price does not reflect its intrinsic value, representing a good opportunity to conduct the buyback.The company's shares were up over 4% in recent morning trade.

HKG:2269

Track with the FINWIRES app suite

FolioX

Track HKG:2269 in your portfolio

WheelAI

Analyze HKG:2269 options with the wheel strategy

StockInsider

See market sentiment on HKG:2269